Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

NCT02111018 is registered in ClinicalTrials.gov with CytoSorbents, Inc as lead sponsor.

NCT NCT02111018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
Lead sponsor
CytoSorbents, Inc
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2014
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhabdomyolysis